Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Purchase | $8.92M | +56.6K | +0.99% | $157.65 | 5.77M | Sep 8, 2022 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Purchase | $9.29M | +56.6K | +0.98% | $164.33 | 5.83M | Sep 9, 2022 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, as amended on May 3, 2022 and August 15, 2022. |
F2 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $150.98 to $159.70. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $159.77 to $166.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |